AVALON GLOBOCARE CORP (AVCO)       0.4421  +0.01 (+2.81%)

0.4421  +0.01 (+2.81%)

US05344R1041 - Common Stock

AVALON GLOBOCARE CORP0.4421

NASDAQ:AVCO (9/26/2022, 11:09:35 AM)+0.01 (+2.81%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Real Estate
GICS Industry Real Estate Management & Development
Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend
Overview
Earnings (Last) 08-15 2022-08-15 Earnings (Next) 11-14 2022-11-14
Ins Owners 33.46% Inst Owners 0.92%
Market Cap 43.86M Shares 99.22M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts N/A
IPO 02-22 2016-02-22

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

AVCO Daily chart

Company Profile

Avalon GloboCare Corp. is a holding company, which engages in the development of biotechnology and the provision of healthcare services. The company is headquartered in Freehold, New Jersey and currently employs 5 full-time employees. The company went IPO on 2016-02-22. The firm provides immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics, and therapeutics. The company operates through two segments: real property and medical related consulting services. Its major clinical programs include AVA-001, AVA-011 and FLASH-CAR, ACTEX, and AVA-Trap. The company also provides strategic advisory and outsourcing services to facilitate and enhance its client's growth and development, as well as competitiveness in healthcare and CellTech industry markets. Its downstream medical team and facility consists of affiliated hospital networks and experts specialized in hematology, oncology, cellular immunotherapy, hematopoietic stem/progenitor cell transplant, as well as regenerative therapeutics. Its services include research studies, executive education, daily online executive briefings, expert advisory services, and consulting and management services.

Company Info

AVALON GLOBOCARE CORP

4400 ROUTE 9, SUITE 3100

Freehold NEW JERSEY 07728

P: 17327804400.0

CEO: David Jin

Employees: 5

Website: http://www.avalon-globocare.com/

AVCO News

News Image2 months ago - Avalon GloboCare Corp.Avalon GloboCare Announces Publication Featuring QTY Code Technology in the Official Journal of the American Chemical Society

Findings support utility of QTY protein code as a novel platform to generate water-soluble proteins for wide spectrum of biomedical applications Reports...

News Image2 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Good morning! It's time for another dive into the biggest pre-market stock movers as we check out what's happening Thursday morning!

News Image3 months ago - Avalon GloboCare Corp.Avalon GloboCare Announces New Study Featuring AI-Enhanced Protein Design Technology Targeting Glucose Transporter Against Cancer

FREEHOLD, N.J., June 30, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

News Image4 months ago - Avalon GloboCare Corp.Avalon GloboCare to Present at the Jefferies 2022 Healthcare Conference

FREEHOLD, N.J., May 25, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (NASDAQ: AVCO), a leading global developer of innovative cell-based technologies...

News Image5 months ago - Get NewsNASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities & Cellular Therapy Developers; Avalon Globocare (NASDAQ: AVCO)News Image5 months ago - Viz ReleaseNASDAQ Biotech AVCO makes Big Moves Filing 16 New Patent Applications, Co-Inventors are leading International Universities and Cellular Therapy Developers; Avalon Globocare Corp. (NASDAQ: AVCO)

AVCO Twits

Here you can normally see the latest stock twits on AVCO, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example